Rankings
▼
Calendar
VCEL Q2 2025 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$63M
+20.1% YoY
Gross Profit
$47M
73.7% margin
Operating Income
-$2M
-3.2% margin
Net Income
-$553,000
-0.9% margin
EPS (Diluted)
$-0.01
QoQ Revenue Growth
+20.2%
Cash Flow
Operating Cash Flow
$8M
Free Cash Flow
$22M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$436M
Total Liabilities
$129M
Stockholders' Equity
$307M
Cash & Equivalents
$81M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$63M
$53M
+20.1%
Gross Profit
$47M
$37M
+27.4%
Operating Income
-$2M
-$6M
+66.4%
Net Income
-$553,000
-$5M
+88.2%
Revenue Segments
MACI Implants And Kits
$53M
100%
← FY 2025
All Quarters
Q3 2025 →